BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 16430717)

  • 1. The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis.
    Gulcelik NE; Akin S; Aydin K; Aydin Mericoz C; Guler Tezel YG; Usman A
    Minerva Endocrinol (Torino); 2023 Dec; 48(4):379-386. PubMed ID: 35775885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the function of EPB41L4A in the predisposition to papillary thyroid carcinoma.
    Comiskey DF; He H; Liyanarachchi S; Sheikh MS; Hendrickson IV; Yu L; Brock PL; de la Chapelle A
    Sci Rep; 2020 Nov; 10(1):19984. PubMed ID: 33203992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HLA-Class I and HLA-Class II Alleles and Mycobacterium Tuberculosis Infection in Iraqi Patients from Baghdad City.
    Mohammed NA; Qassem H; Hassen F
    Iran J Med Sci; 2014 Mar; 39(2 Suppl):191-5. PubMed ID: 24753642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hashimoto's thyroiditis and coexisting disorders in correlation with HLA status-an overview.
    Mikosch P; Aistleitner A; Oehrlein M; Trifina-Mikosch E
    Wien Med Wochenschr; 2023 Feb; 173(1-2):41-53. PubMed ID: 34524590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.
    Shuxian J; Xiaoyun C; Zhihui F; Xiaohua L; Zhanhui D; Bin H; Lin Z
    Thyroid; 2014 May; 24(5):867-71. PubMed ID: 24308748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review.
    Hedayati M; Abooshahab R; Razavi SA; Salehipour P; Ahmadikia K; Boroomand S
    Mol Biol Rep; 2020 Nov; 47(11):8859-8866. PubMed ID: 33106982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis.
    Smerdel A; Lie BA; Ploski R; Koeleman BP; Førre Ø; Thorsby E; Undlien DE
    Arthritis Rheum; 2002 Jun; 46(6):1614-9. PubMed ID: 12115193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Authors' response: association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
    Leite V; Sobrinho LG; Porto T; Martins B; Nunes JM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):549. PubMed ID: 16984252
    [No Abstract]   [Full Text] [Related]  

  • 9. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between HLA-C alleles and papillary thyroid carcinoma.
    Haghpanah V; Khalooghi K; Adabi K; Amiri P; Tavangar SM; Amirzargar A; Ghaffari H; Yazdani N; Nikbin B; Larijani B; Amoli MM
    Cancer Biomark; 2009; 5(1):19-22. PubMed ID: 19242058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile idiopathic arthritis (JIA) is primarily associated with HLA-DR8 but not DQ4 on the DR8-DQ4 haplotype.
    Smerdel A; Ploski R; Flatø B; Musiej-Nowakowska E; Thorsby E; Førre Ø
    Ann Rheum Dis; 2002 Apr; 61(4):354-7. PubMed ID: 11874841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
    Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of HLA antigen in Japanese patients with sarcoidosis].
    Yamaguchi E; Kawakami Y
    Nihon Rinsho; 1994 Jun; 52(6):1443-8. PubMed ID: 8046821
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.